Q: What precautions should be taken when using Pramipexole Extended-Release Tablets 0.75 mg (Pramipexole Dihydrochloride Hydrate)?

This medication is used to treat Parkinson's disease and alleviates symptoms through dopamine action. During treatment, sudden sleep onset or severe drowsiness may occur, so activities such as driving or operating dangerous machinery should be avoided until drowsiness symptoms have completely resolved. Additionally, psychological side effects such as hallucinations or confusion may occur, especially in the elderly, necessitating caution. This medication can lower blood pressure, leading to orthostatic hypotension (dizziness or fainting when standing up), so blood pressure should be closely monitored when starting or increasing the dose. Patients with impaired kidney function or heart disease should consult with their physician before taking this medication and adjust the dose as necessary. This medication can interact with certain drugs, so it's essential to inform healthcare professionals about any other medications being taken, especially when used with sedatives or antihypertensives. The safety of this medication during pregnancy or breastfeeding has not been established, so consult a doctor before deciding to use it. It is not recommended for children as safety and efficacy have not been confirmed. In the case of overdose, symptoms such as nausea, vomiting, hallucinations, and hypotension may occur, thus adherence to prescribed dosages and physician instructions is crucial. Finally, store this medication away from light and moisture, in a place inaccessible to children, and do not transfer it to another container.

Question 1

What are the indications and effects of Pramipexole Extended-Release Tablets 0.75 mg (Pramipexole Dihydrochloride Hydrate)?

Accepted Answer

This medication is used to improve symptoms in patients with idiopathic Parkinson's disease. It is administered alone to early-stage Parkinson's patients, and in advanced patients, it is used in combination with Levodopa to enhance effectiveness. This helps alleviate motor disorders and improves the ability to perform daily activities. This medication plays a crucial role in the treatment of Parkinson's disease, so it is recommended to take it consistently.

Question 2

What are the dosage and administration instructions for Pramipexole Extended-Release Tablets 0.75 mg (Pramipexole Dihydrochloride Hydrate)?

Accepted Answer

Idiopathic Parkinson's disease
Take this medicine once daily at the same time with water. Swallow it whole without chewing, splitting, or crushing it. It may be taken with or without food.
If a dose is missed, take this medicine within 12 hours of the scheduled time. If 12 hours have passed, skip the missed dose and continue with the next dose as scheduled.
1. Patients with normal renal function
1) Initial therapy
Week 1: Total daily dose (mg) 0.375, dose (mg) 0.375
Week 2: Total daily dose (mg) 0.75, dose (mg) 0.75
Week 3: Total daily dose (mg) 1.50, dose (mg) 1.50
Start with a total daily dose of 0.375mg/day and gradually increase it. Increase the dose approximately once every 5-7 days, and do not increase it more frequently. If intolerable adverse reactions do not occur, the dose may be increased to the maximum therapeutic dose. The recommended increments based on clinical trials are as follows.
If further increases are needed, increase by 0.75mg at 1-week intervals, up to a maximum of 4.5mg per day. Patients already taking immediate-release pramipexole may switch to this medicine at the same total daily dose, with the switch made overnight.
2) Maintenance therapy
The dose is 0.375mg to a maximum of 4.5mg per day. In pivotal clinical trials, efficacy was observed starting at a daily dose of 1.5mg during dose escalation in both early and advanced Parkinson's disease. Some patients may experience additional therapeutic benefit at doses higher than 1.5mg. This regimen applies particularly to patients with advanced Parkinson's disease for whom a reduction in levodopa dose is planned. In patients taking this medicine with levodopa, consider reducing the levodopa dose during pramipexole dose escalation and maintenance therapy, as needed to avoid excessive dopaminergic stimulation.
2. Patients with renal impairment
Elimination of pramipexole depends on renal function. The following dosing schedule is suggested for initial therapy;
creatinine CL>50ml/min: No adjustment of daily dose or dosing frequency is necessary.
creatinine CL=30~50ml/min: 0.375mg every 2 days, 2.25mg once daily
creatinine CL<30ml/min: Use of this medicine in these patients has not been adequately studied; consider using immediate-release pramipexole.
If renal function declines during maintenance therapy, follow the recommendations above.
3. Discontinuation
Reduce the dose by 0.75 mg/day until the daily dose has been reduced to 0.75 mg, then reduce it by 0.375 mg/day thereafter.

Question 3

What are the side effects of Pramipexole Extended-Release Tablets 0.75 mg (Pramipexole Dihydrochloride Hydrate)?

Accepted Answer

Drowsiness, hallucinations, confusion, nausea, dizziness, insomnia, constipation, weakness, headache, disorientation, amnesia, impaired perception, ataxia, inability to sit still, abnormal thinking, myoclonus, abnormal vision, erectile dysfunction, general edema, fatigue, decreased appetite, dysphagia, peripheral edema, weight loss, dizziness, insomnia, confusion, amnesia, impaired perception, ataxia, abnormal gait, tension, thirst, forgetfulness, frequent urination, movement disorders, extrapyramidal syndrome, lightheadedness, accidental injury, abnormal dreams, hypokinesia, dyspnea, rhinitis, pneumonia, skin disorders, abnormal near-far adjustment, diplopia, urinary tract infection, urinary incontinence, sleep disorders, syncope, blurred vision, decreased vision, heart failure, hypotension, hiccups, vomiting, pruritus, rash, accident, delirium, intestinal obstruction, hyperkinesia, sudden sleep onset, amnesia, headache, hyperkinesia, syncope, fall accidents, drug toxicity-related arthralgia, traffic accidents, sunburn, tendon rupture, anemia, iron deficiency anemia, leukocytosis, leukopenia, lymphadenitis, lymphadenopathy, thrombocytosis, thrombocytopenia, angina pectoris, ventricular arrhythmia, atrial fibrillation, first-degree atrioventricular block, second-degree atrioventricular block, bradycardia, heart block, cardiac arrest, heart failure, congestive heart failure, cardiomegaly, coronary artery obstruction, cyanosis, ectopic beats, left ventricular failure, myocardial infarction, nodal arrhythmia, sinus arrhythmia, sinus bradycardia, sinus tachycardia, ventricular ectopic beats, ventricular tachycardia, tachycardia, ventricular fibrillation, ventricular ectopy, left ventricular hypertrophy, hearing loss, ear pain, auditory damage, hearing impairment, motion sickness, vestibular dysfunction, goiter, hyperthyroidism, hypothyroidism, transient darkness, blepharitis, eyelid spasms, cataract, acquired lacrimal duct obstruction, dry eye, eye hemorrhage, eye irritation, eye pain, eyelid edema, ptosis, glaucoma, keratitis, macular degeneration, myopia, photophobia, retinal detachment, retinal vascular disorder, scotoma, blurred vision, decreased vision, vitreous floaters, abdominal discomfort, abdominal bloating, aphthous ulcer, ascites, cheilitis, colitis, ulcerative colitis, duodenal ulcer, duodenal ulcer bleeding, enteritis, belching, fecal incontinence, gastric ulcer, gastric ulcer bleeding, gastritis, gastrointestinal bleeding, gastroesophageal reflux disease, gingivitis, hematemesis, melena, hemorrhoids, diaphragmatic hernia, excessive hydrochloric acid, intestinal obstruction, inguinal hernia, bowel obstruction, irritable bowel syndrome, esophageal spasm, esophageal stricture, esophagitis, pancreatitis, periodontitis, rectal bleeding, reflux esophagitis, glossitis, glossal ulcer, toothache, umbilical hernia, thoracic discomfort, chills, death, drug withdrawal symptoms, facial swelling, fever sensation, irritability, abnormal gait, wound healing dysfunction, influenza-like symptoms, irritability, localized edema, edema, dependent edema, thirst, biliary spasm, cholecystitis, chronic cholecystitis, cholelithiasis, drug hypersensitivity, abscess, acute tonsillitis, appendicitis, bronchiolitis, bronchitis, bronchiolitis pneumonia, cellulitis, cystitis, dental caries, diverticulitis, otitis media, eye infection, folliculitis, fungal infection, boil, necrosis, gastroenteritis, gingivitis, herpes simplex, shingles, chalazion, intervertebral disc disease, laryngitis, lobar pneumonia, nail infection, onychomycosis, oral candidiasis, orchitis, osteomyelitis, otitis externa, otitis media, paronychia, pyelonephritis, pyoderma, sepsis, skin infection, tonsillitis, tooth abscess, tooth infection, upper respiratory tract infection, urethritis, vaginal candidiasis, vaginal infection, viral infection, wound infection, fall accidents, drug toxicity-related arthralgia, traffic accidents, sunburn, tendon rupture, cachexia, decreased appetite, dehydration, diabetes, fluid retention, gout, hypercholesterolemia, hyperglycemia, hyperlipidemia, hyperuricemia, hypocalcemia, hypoglycemia, hypokalemia, hyponatremia, vitamin deficiency, increased appetite, metabolic alkalosis, bone pain, myofascial pain, flank pain, intervertebral disc disorder, intervertebral disc protrusion, joint effusion, joint stiffness, joint swelling, monoarthritis, muscle rigidity, muscle cramp, musculoskeletal rigidity, myopathy, myositis, neck stiffness, osteoarthritis, necrosis of bone, osteoporosis, fibromyalgia, rheumatoid arthritis, shoulder pain, spondyloarthritis, tendinitis, tenosynovitis, abdominal tumor, adenoma, benign adenoma, basal cell carcinoma, bladder cancer, breast cancer, breast tumor, chronic lymphocytic leukemia, colon cancer, rectal cancer, endometrial cancer, gallbladder cancer, gastric cancer, gastrointestinal tumors, hemangioma, liver tumor, malignant liver tumor, lip and oral cancer, malignant lung tumor, metastatic lung cancer, lymphoma, malignant melanoma, melanocytic nevus, pulmonary metastasis, multiple myeloma, benign oral tumor, tumor, malignant tumor, prostate tumor, skin tumor, neuroma, ovarian cancer, prostate cancer, prostate adenoma, pseudolymphoma, kidney tumor, skin cancer, skin papilloma, squamous cell carcinoma, thyroid tumor, uterine leiomyoma, ageusia, akinesia, anticholinergic syndrome, aphasia, balance disorder, brain edema, carotid artery obstruction, carpal tunnel syndrome, cerebral artery embolism, cerebral hemorrhage, cerebral infarction, cerebral ischemia, chorea, cognitive impairment, coma, seizure, coordination disorder, dementia, decreased perceptual level, attention disorder, postural dizziness, stuttering, writing disorder, facial paralysis, grand mal seizure, hemiplegia, hypersensitivity, hyperkinesia, hyperreflexia, hyporeflexia, hypotonia, drowsiness disorder, loss of consciousness, amnesia, migraine, involuntary muscle contraction, narcolepsy, neuralgia, neuropathy, nystagmus, olfactory dysfunction, psychomotor agitation, sciatica, sedation, sensory impairment, sleep rhythm disorder, somnambulism, confusion, vasovagal syncope, tension headache, emotional instability, aggression, anxiety, mental dullness, bruxism, suicide, psychotic disturbance, delusions, paranoia, disorientation, dissociation, emotional tension, euphoria, auditory hallucination, visual hallucination, initial insomnia, increased libido, hypomania, mid insomnia, mood swings, nightmares, obsession, obsessive-compulsive disorder, panic response, hypersomnia, personality disorder, mental disorder, restlessness, somnambulism, suicidal ideation, chromaturia, dysuria, diabetes, hematuria, urgency, nephrolithiasis, neurogenic bladder, enuresis, oliguria, polyuria, proteinuria, renal artery stenosis, renal colic, renal cyst, renal failure, renal impairment, urinary retention, amenorrhea, mastalgia, dysmenorrhea, epididymitis, gynecomastia, menopausal symptoms, menorrhagia, uterine bleeding, ovarian mass, priapism, prostatitis, sexual dysfunction, uterine hemorrhage, leukorrhea, vaginal bleeding, transient respiratory arrest, inspiration, asthma, asphyxia, chronic obstructive pulmonary disease, throat dryness, speech impairment, exertional dyspnea, epistaxis, hemoptysis, hiccups, tachypnea, bronchial secretion increase, laryngospasm, nasal dryness, nasal polyps, obstructive airway anomaly, pharyngodynia, pleurisy, aspiration pneumonia, pneumothorax, postnasal drip syndrome, productive cough, pulmonary embolism, pulmonary edema, respiratory alkalosis, respiratory distress syndrome, respiratory failure, pulmonary congestion, allergic rhinitis, rhinorrhea, sinus congestion, sleep apnea, sneezing, snoring, hypopnea, wheezing, acne, hair loss, sweating, skin cyst, dermatitis, vesicular dermatitis, contact dermatitis, dry skin, petechiae, eczema, erythema, corneal thickening, livedo reticularis, sweating, periocular edema, petechiae, phototoxic allergy symptoms, psoriasis, purpura, erythematous eczema, maculopapular erythema, papular erythema, rhinophyma, seborrhea, seborrheic dermatitis, skin burning sensation, skin depigmentation, skin peeling, skin hyperpigmentation, skin hypertrophy, skin irritation, skin laceration, atypical body odor, skin ulcer, urticaria, aneurysm, vascular pathology, atherosclerosis, circulatory disturbance, deep vein thrombosis, embolism, thrombus, facial flushing, hypertensive crisis, lymphatic edema, pallor, phlebitis, Raynaud's disease, shock, thrombotic phlebitis, thrombus, varicose veins

Question 4

What precautions should be taken when using Pramipexole Extended-Release Tablets 0.75 mg (Pramipexole Dihydrochloride Hydrate)?

Accepted Answer

This medication is used to treat Parkinson's disease and alleviates symptoms through dopamine action.

During treatment, sudden sleep onset or severe drowsiness may occur, so activities such as driving or operating dangerous machinery should be avoided until drowsiness symptoms have completely resolved.

Additionally, psychological side effects such as hallucinations or confusion may occur, especially in the elderly, necessitating caution.

This medication can lower blood pressure, leading to orthostatic hypotension (dizziness or fainting when standing up), so blood pressure should be closely monitored when starting or increasing the dose.

Patients with impaired kidney function or heart disease should consult with their physician before taking this medication and adjust the dose as necessary.

This medication can interact with certain drugs, so it's essential to inform healthcare professionals about any other medications being taken, especially when used with sedatives or antihypertensives.

The safety of this medication during pregnancy or breastfeeding has not been established, so consult a doctor before deciding to use it.

It is not recommended for children as safety and efficacy have not been confirmed.

In the case of overdose, symptoms such as nausea, vomiting, hallucinations, and hypotension may occur, thus adherence to prescribed dosages and physician instructions is crucial.

Finally, store this medication away from light and moisture, in a place inaccessible to children, and do not transfer it to another container.

Pramipexole Extended-Release Tablets 0.75 mg (Pramipexole Dihydrochloride Hydrate)

Summary

Ingredients

Efficacy & effects

How to take

Adult dose

Precautions

Side effects

Storage

Appearance and packaging

Appearance

Package unit

Same-ingredient medicines

Pramipexole Extended-Release Tablets 0.75 mg (Pramipexole Dihydrochloride Hydrate)

Mirapex Tablets 0.125 mg (Pramipexole Dihydrochloride Monohydrate)

Mirapex Tablets 0.25 mg (Pramipexole Hydrochloride Trihydrate)

Mirapex Tablets 0.5 mg (Pramipexole Hydrochloride Dihydrate)

Mirapex Tablet 1.0 mg (Pramipexole Hydrochloride Dihydrate)

Mirapex Extended Release Tablet 1.5 mg (Pramipexole Dihydrochloride Monohydrate)

Mirapex Extended-Release Tablet 0.75 mg (Pramipexole Dihydrochloride Monohydrate)

Mirapex Sustained Release Tablet 0.375 mg (Pramipexole Dihydrochloride Monohydrate)

Questions about this medicine

Related searches

Search tags

Suggested searches